APA

Tada H., Matsui S., Kawahara M., Hosoe S., Hamada C. & Fukushima M. (20080805). Efficacy, toxicity and cost analysis for non-platinum triplet (gemcitabine and vinorelbine, followed by docetaxel) vs. platinum-based chemotherapy in IIIB/IV non-small-cell lung cancer: single-institution experience. : European journal of cancer care.

Chicago

Tada H, Matsui S, Kawahara M, Hosoe S, Hamada C and Fukushima M. 20080805. Efficacy, toxicity and cost analysis for non-platinum triplet (gemcitabine and vinorelbine, followed by docetaxel) vs. platinum-based chemotherapy in IIIB/IV non-small-cell lung cancer: single-institution experience. : European journal of cancer care.

Harvard

Tada H., Matsui S., Kawahara M., Hosoe S., Hamada C. and Fukushima M. (20080805). Efficacy, toxicity and cost analysis for non-platinum triplet (gemcitabine and vinorelbine, followed by docetaxel) vs. platinum-based chemotherapy in IIIB/IV non-small-cell lung cancer: single-institution experience. : European journal of cancer care.

MLA

Tada H, Matsui S, Kawahara M, Hosoe S, Hamada C and Fukushima M. Efficacy, toxicity and cost analysis for non-platinum triplet (gemcitabine and vinorelbine, followed by docetaxel) vs. platinum-based chemotherapy in IIIB/IV non-small-cell lung cancer: single-institution experience. : European journal of cancer care. 20080805.